The urinalysis market had a value of USD 3.5 billion in 2022 and is projected to reach USD 5.6 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.5% during the forecast period. Key drivers of market revenue growth include the increasing prevalence of kidney disorders and urinary tract infections, the growing adoption of Point-Of-Care Testing (POCT), and ongoing advancements...
English
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt